Goodwin advised Nimbus Therapeutics on the financing.Nimbus Therapeutics announced its $210 million private financing to advance its next wave of tech-enabled small molecule medicines. The round…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
